Attached files
| file | filename |
|---|---|
| EX-10.1 - FORM OF PROMISSORY NOTE AMENDMENT DATED MAY 23, 2011 - THERALINK TECHNOLOGIES, INC. | exhibit10-1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act
of 1934
Date of Report (Date of earliest event reported) May 23, 2011
PEDIATRX INC.
(Exact name
of registrant as specified in its charter)
| Nevada | 000-52218 | 20-2590810 |
| (State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
| 405 Trimmer Road, Suite 200, Califon, NJ | 07830 |
| (Address of principal executive offices) | (Zip Code) |
Registrant’s telephone number, including area code (908) 975-0753
N/A
(Former name or former address, if changed
since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ] Written communications pursuant to Rule 425 under the
Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule
14a-12 under the Exchange Act (17 CFR 240.14a -12)
[ ] Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d
-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under
the Exchange Act (17 CFR 240.13e -4(c))
| Item 1.01 | Entry into a Material Definitive Agreement. |
Please see the disclosure under Item 2.03 of this current report on Form 8-K.
| Item 2.03 | Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. |
On May 23, 2011, we entered into an amendment of an unsecured promissory note dated July 26, 2010 in the principal amount of $200,000 with simple interest at a rate of 5% per annum whereby we extended the maturity date of the note from July 26, 2011 until July 26, 2012.
All other terms of the promissory note remain the same.
| Item 9.01 | Financial Statements and Exhibits. |
| (d) | Exhibits. |
| 10.1 | Form of Promissory Note Amendment dated May 23, 2011 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| PEDIATRX INC. | |
| /s/ Cameron Durrant | |
| Cameron Durrant | |
| President, Chief Executive Officer and Director | |
| Date: May 23, 2011 |